CHINA PREPARES TO RELEASE NEW COVID DRUG WITH PFIZER

HONG KONG/BEIJING, Jan 6 (Reuters) - China is in talks with Pfizer to secure a license that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm's COVID-19 antiviral drug Paxlovid in China, three sources told Reuters.

Learn More